发明名称 Neocarzinostatin derivatives and a process for manufacturing the same.
摘要 <p>Neocarzinostatin derivatives. having excellent anticancer activity, have the formula (A) (SMA)-(NCS)-(SMA) (A) wherein (NCS) represents a divalent neocarzinostatin residue in which a hydrogen atom has been removed from each of the primary amino group of the alanine residue at the N-terminal of neocarzinostatin and of the primary amino group of the lysine residue at the 20th position from the N-terminal of neocarzinostatin and (SMA) represents a monovalent styrene-maleic acid copolymer residue having a weight-average molecular weight of from 800 to 2,500 and consisting of structural units of (a) the styrene residue &lt;CHEM&gt; (b) the maleic acid residue &lt;CHEM&gt; and (c) a residue having the following formula in which a hydroxyl group of one carboxylic group of a maleic acid residue has been removed to provide the link bonding the monovalent styrene-maleic acid copolymer residue to the necarzinostatin residue &lt;CHEM&gt; </p>
申请公布号 EP0136792(A2) 申请公布日期 1985.04.10
申请号 EP19840305414 申请日期 1984.08.08
申请人 KURARAY CO., LTD.;YAMANOUCHI PHARMACEUTICAL CO. LTD.;KAYAKU ANTIBIOTICS RESEARCH CO., LTD.;MAEDA, HIROSHI 发明人 MAEDA, HIROSHI;KANAMARU, RYUNOSUKE;ISHIDA, NAKAO;YOSHITAKE, TOSHIHIKO;UEDA, MINORU
分类号 A61K38/00;A61P35/00;C07K1/107;C07K1/113;C07K14/00;C07K14/195;C07K14/41;C07K17/08;C08F8/00;(IPC1-7):C07K15/00;C08F222/08;A61K37/02 主分类号 A61K38/00
代理机构 代理人
主权项
地址